<DOC>
	<DOCNO>NCT02187198</DOCNO>
	<brief_summary>This randomize , open-label clinical trial 200 Veteran opioid dependent men woman . Veterans randomize one two treatment group : low dose range buprenorphine ( &lt; 8mg ) vs. high dose range buprenorphine ( &lt; 16mg ) . During induction buprenorphine , participant start dose 2mg , dose increase need stabilization opioid withdrawal symptom , 8mg low dose group , 16mg high dose group , within 5 day period . Participants see daily basis ( exclude weekend ) initial 5 day induction . At end 12-week study , participant either refer buprenorphine clinic wish continue medication , wish drug free , undergo detoxification buprenorphine 4-week period . Follow-up visit , schedule 1 , 3 , 6 month study completion , evaluate durability treatment effect drug use psychosocial outcome . Veterans recruit primarily advertisement , also clinical facility VA collaborator .</brief_summary>
	<brief_title>Buprenorphine Treatment Opioid Dependence</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>1 . Males female age 18 65 , current dependence prescription opioids evidence documented prior treatment opioid dependence , sign opiate withdrawal evidence COWS score 7 great , selfreported history opioid dependence , positive urine toxicology opiate ; 2. willingness detoxify opioids buprenorphine maintenance ; 3. woman childbearing age , negative pregnancy test screening agreement use adequate contraception prevent pregnancy , monthly pregnancy test obtain study participation . 1. use heroin 4 day past month ; 2. lifetime history opioid dependence due heroin alone ; 3. ever use heroin intravenously ; 4. requirement current ongoing opioid treatment adequate pain management ; 5. current alcohol , benzodiazepine , barbiturate use physiologic dependence determine screen history physical , 6. serious unstable medical illness include bradycardia arrhythmia , major cardiovascular , renal , endocrine , hepatic disorder buprenorphine treatment contraindicate determination MD medically dangerous ; 7. serious psychiatric illness include psychosis , bipolar disorder psychosis : 8. significant current suicidal homicidal thought necessitate high level care ; 9. know allergy intolerance buprenorphine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Opioid Dependence</keyword>
	<keyword>Buprenorphine</keyword>
</DOC>